呼吸器・乳腺外科学
Thoracic and Breast Surgery
整理番号

論文の種類

著者名 タイトル・題名 雑誌名
書名  外
巻(号) ページ 発行年
Corresponding
Author
1846001 総説 杉尾 賢二*. 非小細胞肺癌に対する周術期治療の期待 胸部外科 71(4), 249-255, 2018  
1846002 原著 Saji H*, Ueno T, Nakamura H, Okumura N, Tsuchida M, Sonobe M, Miyazaki T, Aokage K, Nakao M, Haruki T, Ito H, Kataoka K, Okabe K, Tomizawa K, Yoshimoto K, Horino H, Sugio K A proposal of comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303. Eur J Cardiothorac Surg. 53(4) 35-841 2018  
1846003 原著 Kometani T*, Sugio K, Osoegawa A, Seto T, Ichinose Y.  Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.  Thorac Cancer. 9(5) 563-570 2018  
1846004 原著 Okamoto T*, Takada K, Sato S, Toyokawa G, Tagawa T, Shoji F, Nakanishi R, Oki E, Koike T, Nagahashi M, Ichikawa H, Shimada Y, Watanabe S, Kikuchi T, Akazawa K, Lyle S, Takabe K, Okuda S, Sugio K, Wakai T, Tsuchida M, Maehara Y.  Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung.  Ann Surg Oncol.  25(6) 1564-1571 2018  
1846005 原著 Hashimoto T*, Osoegawa A, Takumi Y, Abe M, Kobayashi R, Miyawaki M, Takeuchi H, Okamoto T, Sugio K.  Intratumoral heterogeneity of copy number variation in lung cancer harboring L858R via immunohistochemical heterogeneous staining.  Lung Cancer. 124 241-247 2018  
1846006 原著 Okamoto T*, Yano T, Shimokawa M, Takeo S, Yamazaki K, Sugio K, Takenoyama M, Nagashima A, Tsukamoto S, Hamatake M, Yokoyama H, Ueda H, Motohiro A, Tagawa T, Shoji F, Kometani T, Saito G, Fukuyama Y, Toyokawa G, Osoegawa A, Emi Y, Maehara Y. A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer. Lung Cancer. 124 255-259 2018  
1846007 原著 Osoegawa A*, Hashimoto T, Takumi Y, Abe M, Yamada T, Kobayashi R, Miyawaki M, Takeuchi H, Okamoto T, Sugio K. Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation.  Invest New Drugs. 36(6) 999-1005 2018